Transcode Therapeutics

RNAZ NASDAQ
Overview Stats Financials News

Price & Volume

Stats

See more
52W Range $0.42-$309.60
Market Cap $5.2M
Shares Short 149,637

Financials

See more
Revenue (12 Mos) $0
Revenue Growth (YoY) 0%
Gross Profit (12 Mos) $0
Diluted EPS -$4,144.40

About

CEO Mr. Thomas A. Fitzgerald M.B.A.
CFO Mr. Thomas A. Fitzgerald M.B.A.
Address 6 Liberty Square, Boston, MA, United States, 02109
Sector Healthcare
Industry Biotechnology
Full-Time Employees 10